Health Technology Assessments

Health Technology Assessments (HTAs) are a comprehensive systematic review and critical analysis of available evidence for A SINGLE medical technology for which there are several published clinical trials and a substantial body of evidence. This report details an entire technology class for which there are one or more indications or patient populations in use.

Our analysts evaluate clinical trial data, along with information regarding safety issues, coverage policies from the private and public sectors, regulatory approvals, consensus statements, and an overall projection of the potential clinical efficacy and economic impact of the technology. Reports are reviewed annually up to 5 years post publication to determine if there is new literature or evidence that would impact a change in rating and warrant an updated report.

Eversense Continuous Glucose Monitoring System for Maintaining Glycemic Control in Adults with Diabetes Mellitus

Focus of the Report: This Health Technology Assessment focuses on the use of the Eversense Continuous Glucose Monitoring (CGM) System (Senseonics Inc.). This minimally invasive, implantable CGM device is used to continuously monitor interstitial glucose levels in patients with diabetes mellitus (DM), with the goal of improving glycemic control and long-term outcomes.

read more

Mechanochemical Endovenous Ablation (MOCA) with the ClariVein Infusion Catheter Nonthermal Vein Ablation System (Merit Medical Systems Inc.) for Treatment of Varicose Veins

Focus of the Report: This Health Technology Assessment focuses on the use of mechanochemical endovenous ablation (MOCA), a nonthermal type of ablation for treatment of varicose veins, with the ClariVein infusion catheter (Merit Medical Systems Inc.).

Technology Description: The ClariVe…

read more